Atlas Trials

GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM

Clinical trial NCT05695976 · SUSPENDED

Trial details

NCT number
NCT05695976
Sponsor
Duke University
Status
SUSPENDED
Study type
OBSERVATIONAL
GlioblastomaGlioma, Malignant
Start date
2023-04-18
Primary completion
2029-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.